| 变量 | 总数(n = 459) | 模型组(n = 321) | 验证组(n = 138) | Z/χ2值 | P值 |
| 术中出血mL，M (Q1, Q3) | 150.00 (100.00, 300.00) | 150.00 (100.00, 300.00) | 200.00 (100.00, 300.00) | Z = −0.99 | 0.32 |
| 间接胆红μmol/L，M (Q1, Q3) | 11.71 (8.93, 15.30) | 11.80 (9.00, 15.46) | 11.43 (8.83, 15.07) | Z = −0.65 | 0.52 |
| Child-pugh肝功能分级，n (%) |
|
|
| χ2 = 0.00 | 1.00 |
| A | 448 (97.60) | 313 (97.51) | 135 (97.83) |
|
|
| B | 11 (2.40) | 8 (2.49) | 3 (2.17) |
|
|
| 是否复发，n (%) |
|
|
| χ2 = 0.18 | 0.67 |
| 否 | 296 (64.49) | 209 (65.11) | 87 (63.04) |
|
|
| 是 | 163 (35.51) | 112 (34.89) | 51 (36.96) |
|
|
| 性别，n (%) |
|
|
| χ2 = 0.18 | 0.67 |
| 女 | 75 (16.34) | 54 (16.82) | 21 (15.22) |
|
|
| 男 | 384 (83.66) | 267 (83.18) | 117 (84.78) |
|
|
| 年龄 > 50岁，n (%) |
|
|
| χ2 = 2.88 | 0.09 |
| 否 | 125 (27.23) | 80 (24.92) | 45 (32.61) |
|
|
| 是 | 334 (72.77) | 241 (75.08) | 93 (67.39) |
|
|
| 甲胎蛋白 > 1000 ng/mL，n (%) |
|
|
| χ2 = 0.01 | 0.93 |
| 否 | 377 (82.14) | 264 (82.24) | 113 (81.88) |
|
|
| 是 | 82 (17.86) | 57 (17.76) | 25 (18.12) |
|
|
| 单细胞百分比 > 3%，n (%) |
|
|
| χ2 = 0.21 | 0.64 |
| 否 | 387 (84.31) | 269 (83.80) | 118 (85.51) |
|
|
| 是 | 72 (15.69) | 52 (16.20) | 20 (14.49) |
|
|
| 单细胞计数 > 0.1 × 109/L，n (%) |
|
|
| χ2 = 0.02 | 0.88 |
| 否 | 404 (88.02) | 283 (88.16) | 121 (87.68) |
|
|
| 是 | 55 (11.98) | 38 (11.84) | 17 (12.32) |
|
|
| 淋巴细胞百分比 > 20%，n (%) |
|
|
| χ2 = 1.41 | 0.23 |
| 否 | 45 (9.80) | 28 (8.72) | 17 (12.32) |
|
|
| 是 | 414 (90.20) | 293 (91.28) | 121 (87.68) |
|
|
| 淋巴细胞计数 > 0.8 × 109 L，n (%) |
|
|
| χ2 = 0.60 | 0.44 |
| 否 | 77 (16.78) | 51 (15.89) | 26 (18.84) |
|
|
| 是 | 382 (83.22) | 270 (84.11) | 112 (81.16) |
|
|
| 嗜碱性粒细胞百分比 > 1%，n (%) |
|
|
| χ2 = 2.11 | 0.15 |
| 否 | 431 (93.90) | 298 (92.83) | 133 (96.38) |
|
|
| 是 | 28 (6.10) | 23 (7.17) | 5 (3.62) |
|
|
| 嗜碱性粒细胞计数 > 0.8 × 109/L，n (%) |
|
|
| χ2 = 0.00 | 0.99 |
| 否 | 439 (95.64) | 307 (95.64) | 132 (95.65) |
|
|
| 是 | 20 (4.36) | 14 (4.36) | 6 (4.35) |
|
|
| 嗜酸性粒细胞百分比 > 0.5%，n (%) |
|
|
| χ2 = 0.26 | 0.61 |
| 否 | 23 (5.01) | 15 (4.67) | 8 (5.80) |
|
|
| 是 | 436 (94.99) | 306 (95.33) | 130 (94.20) |
|
|
| 嗜酸性粒细胞计数 > 50 × 106/L，n (%) |
|
|
| χ2 = 0.13 | 0.72 |
| 否 | 13 (2.83) | 8 (2.49) | 5 (3.62) |
|
|
| 是 | 446 (97.17) | 313 (97.51) | 133 (96.38) |
|
|
| 中性粒细胞百分比 > 42%，n(%) |
|
|
| χ2 = 1.21 | 0.27 |
| 否 | 28 (6.10) | 17 (5.30) | 11 (7.97) |
|
|
| 是 | 431 (93.90) | 304 (94.70) | 127 (92.03) |
|
|
| 中性粒细胞计数 > 2 × 109/L，n (%) |
|
|
| χ2 = 0.45 | 0.50 |
| 否 | 56 (12.20) | 37 (11.53) | 19 (13.77) |
|
|
| 是 | 403 (87.80) | 284 (88.47) | 119 (86.23) |
|
|
| 乙肝感染，n (%) |
|
|
| χ2 = 0.04 | 0.85 |
| 否 | 48 (10.46) | 33 (10.28) | 15 (10.87) |
|
|
| 是 | 411 (89.54) | 288 (89.72) | 123 (89.13) |
|
|
| 乙肝病毒DNA > 1000 IU/mL，n (%) |
|
|
| χ2 = 0.15 | 0.70 |
| 否 | 302 (65.80) | 213 (66.36) | 89 (64.49) |
|
|
| 是 | 157 (34.20) | 108 (33.64) | 49 (35.51) |
|
|
| 乙肝表面抗原，n (%) |
|
|
| χ2 = 0.12 | 0.73 |
| 阴性 | 57 (12.42) | 41 (12.77) | 16 (11.59) |
|
|
| 阳性 | 402 (87.58) | 280 (87.23) | 122 (88.41) |
|
|
| 乙肝前S1抗原，n (%) |
|
|
| χ2 = 0.00 | 0.97 |
| 阴性 | 77 (16.78) | 54 (16.82) | 23 (16.67) |
|
|
| 阳性 | 382 (83.22) | 267 (83.18) | 115 (83.33) |
|
|
| 乙肝e抗原，n (%) |
|
|
| χ2 = 0.01 | 0.92 |
| 阴性 | 125 (27.23) | 87 (27.10) | 38 (27.54) |
|
|
| 阳性 | 334 (72.77) | 234 (72.90) | 100 (72.46) |
|
|
| 谷氨酰基转移酶 > 32 U/L，n (%) |
|
|
| χ2 = 0.03 | 0.87 |
| 否 | 335 (72.98) | 235 (73.21) | 100 (72.46) |
|
|
| 是 | 124 (27.02) | 86 (26.79) | 38 (27.54) |
|
|
| 肿瘤分化，n (%) |
|
|
| χ2 = 3.25 | 0.07 |
| 高分化 | 262 (57.08) | 192 (59.81) | 70 (50.72) |
|
|
| 中低分化 | 197 (42.92) | 129 (40.19) | 68 (49.28) |
|
|
| 肿瘤最大直径 > 5 cm，n (%) |
|
|
| χ2 = 0.19 | 0.67 |
| 否 | 306 (66.67) | 216 (67.29) | 90 (65.22) |
|
|
| 是 | 153 (33.33) | 105 (32.71) | 48 (34.78) |
|
|
| 肿瘤数量 > 1，n (%) |
|
|
| χ2 = 1.17 | 0.28 |
| 否 | 425 (92.59) | 300 (93.46) | 125 (90.58) |
|
|
| 是 | 34 (7.41) | 21 (6.54) | 13 (9.42) |
|
|
| 被膜侵犯，n (%) |
|
|
| χ2 = 2.82 | 0.09 |
| 否 | 269 (58.61) | 180 (56.07) | 89 (64.49) |
|
|
| 是 | 190 (41.39) | 141 (43.93) | 49 (35.51) |
|
|
| 微血管侵犯，n (%) |
|
|
| χ2 = 0.04 | 0.85 |
| 否 | 236 (51.42) | 166 (51.71) | 70 (50.72) |
|
|
| 是 | 223 (48.58) | 155 (48.29) | 68 (49.28) |
|
|
| 卫星结节，n (%) |
|
|
| χ2 = 0.04 | 0.84 |
| 否 | 398 (86.71) | 279 (86.92) | 119 (86.23) |
|
|
| 是 | 61 (13.29) | 42 (13.08) | 19 (13.77) |
|
|
| 肝硬化，n (%) |
|
|
| χ2 = 0.00 | 0.98 |
| 否 | 170 (37.04) | 119 (37.07) | 51 (36.96) |
|
|
| 是 | 289 (62.96) | 202 (62.93) | 87 (63.04) |
|
|
| 抗病毒治疗，n (%) |
|
|
| χ2 = 2.34 | 0.13 |
| 否 | 93 (20.26) | 59 (18.38) | 34 (24.64) |
|
|
| 是 | 366 (79.74) | 262 (81.62) | 104 (75.36) |
|
|
| 术后预防性介入，n (%) |
|
|
| χ2 = 0.19 | 0.66 |
| 否 | 365 (79.52) | 257 (80.06) | 108 (78.26) |
|
|
| 是 | 94 (20.48) | 64 (19.94) | 30 (21.74) |
|
|
| BCLC分期，n (%) |
|
|
| χ2 = 1.26 | 0.53 |
| 0 | 73 (15.90) | 54 (16.82) | 19 (13.77) |
|
|
| A | 368 (80.17) | 256 (79.75) | 112 (81.16) |
|
|
| B | 18 (3.92) | 11 (3.43) | 7 (5.07) |
|
|
| CNLC分期，n (%) |
|
|
| χ2 = 0.69 | 0.40 |
| Ia + Ib | 441 (96.08) | 310 (96.57) | 131 (94.93) |
|
|
| II + III | 18 (3.92) | 11 (3.43) | 7 (5.07) |
|
|
| TNM, n (%) |
|
|
| χ2 = 1.17 | 0.28 |
| T1 | 425 (92.59) | 300 (93.46) | 125 (90.58) |
|
|
| T2 | 34 (7.41) | 21 (6.54) | 13 (9.42) |
|
|